Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer

International Journal of Gynecological Cancer

Volumn 12, Issue 5, 2002, Pages 459-464

  Sood, B M ^a,b   Timmins, P F ^a   Gorla, G R ^a   Garg, M ^a   Anderson, P S ^a   Vikram, B ^a   Goldberg, G L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Cervix cancer; Chemotherapy; Endometrial cancer; Extended field radiation therapy

Indexed keywords

CISPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; DEHYDRATION; DIARRHEA; DISEASE SEVERITY; DRUG SAFETY; ENDOMETRIUM CANCER; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LAPAROTOMY; MORBIDITY; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; RISK BENEFIT ANALYSIS; SEPSIS; THROMBOCYTOPENIA; UTERINE CERVIX CANCER; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0036743437     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01172.x     Document Type: Article

References (26)

1. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 1987;60 (8 Suppl.):2035-41.
2. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
3. Inoue T. Prognostic significance of the depth of invasion relating to nodal metastases, parametrial extension, and cell types. A study of 628 cases with Stage IB, IIA, and IIB cervical carcinoma. Cancer 1984;54:3035-42.
4. Delgado G, Bundy BN, Fowler WC Jr et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989;35:314-20.
5. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990;65:1923-7.
6. Rubin SC, Brookland R, Mikuta JJ, Mangan C, Sutton G, Danoff B. Para-aortic nodal metastases in early cervical carcinoma: long-term survival following extended-field radiotherapy. Gynecol Oncol 1984;18:213-7.
7. Weiser EB, Bundy BN, Hoskins WJ et al. Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study). Gynecol Oncol 1989;33:283-9.
8. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991;67:2776-85.
9. Rotman M, Pajak TF, Choi K et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995;274:387-93.
10. Malfetano JH, Keys HM, Cunningham MJ, Gibbons S, Ambros R. Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma. Gynecol Oncol 1997;67:203-7.
11. Malfetano J, Keys H, Kredentser D, Cunningham M, Kotlove D, Weiss L. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 1993;71:3703-6.
12. Varia MA, Bundy BN, Deppe G et al. Cervical carcinoma metastatic to para-aortic nodes. extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998;42:1015-23.
13. Thomas L, Bataillard A, Bremond A et al. [Standards, options, and recommendations for the radiotherapy of patients with endometrial cancer. FNCLCC (Natl Federation Cancer Campaign Centers) CRLCC (Regional Cancer Campaign Centers)]. Cancer Radiother 2001;5:163-92.
14. Mundt AJ, Murphy KT, Rotmensch J, Waggoner SE, Yamada SD, Connell PP. Surgery and postoperative radoiotherapy in FIGO Stage IIIC endometrial carcinoma. Int J Radiat Oncol Biol Phys 2001;50:1154-60.
15. Potish RA, Twiggs LB, Adcock LL, Savage JE, Levitt SH, Prem KA. Paraaortic lymph node radiotherapy in cancer of the uterine corpus. Obstet Gynecol 1985;65:251-6.
16. Fields AL, Anderson PS, Goldberg GL et al. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix. Gynecol Oncol 1996;61:416-22.
17. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, Mortel R. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 1980;138:550-6.
18. Berman ML, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol 1984;19:8-16.
19. Komaki R, Cox JD, Hartz A, Wilson JF, Greenberg M. Influence of preoperative irradiation on failures of endometrial carcinoma with high risk of lymph node metastasis. Am J Clin Oncol 1984;7:661-8.
20. Salazar OM, Feldstein ML, DePapp EW et al. Endometrial carcinoma. analysis of failures with special emphasis on the use of initial preoperative external pelvic radiation. Int J Radiat Oncol Biol Phys 1977;2:1101-7.
21. Rose PG, Eifel PJ. Combined radiation therapy and chemotherapy for carcinoma of the cervix. Cancer J 2001;7:86-94.
22. Ballon SC, Berman ML, Lagasse LD, Petrilli ES, Castaldo TW. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol 1981;57:90-5.
23. Lovecchio JL, Averette HE, Donato D, Bell J. 5-year survival of patients with periaortic nodal metastases in clinical stage IB and IIA cervical carcinoma. Gynecol Oncol 1989;34:43-5.
24. Haie C, Pejovic MH, Gerbaulet A et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol 1988;11:101-12.
25. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
26. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.